AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9610859 — intervention group
Group type: EXPERIMENTAL
Intervention: Disinfection solution
Number of subjects: 0
Study 9610859 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 0
Study 7799651 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-rapid reinforcing-reducing method
Number of subjects: 85
Study 7799651 — intervention group
Group type: COMPARATOR
Intervention: Flat twisting method
Number of subjects: 85
Study 3389317 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking program during gestational weeks 22‐30 (n = 18)
Number of subjects: 28
Study 3389317 — intervention group
Group type: COMPARATOR
Intervention: Nonwalking group (n = 10)
Number of subjects: 28
Study 30877622 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-02 (sumatriptan 10 mg nasal spray)
Number of subjects: 107
Study 30877622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 30118887 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in Mental Imagery (TMI)
Number of subjects: 111
Study 30118887 — intervention group
Group type: COMPARATOR
Intervention: Control Training in Verbal Thinking (TVT)
Number of subjects: 111
Study 30118887 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list Control Group
Number of subjects: 111
Study 27342433 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive stimulation plus enhanced nutrition
Number of subjects: 1302
Study 27342433 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive stimulation alone
Number of subjects: 1302
Study 27342433 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced nutrition alone
Number of subjects: 1302
Study 27342433 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (responsive stimulation plus enhanced nutrition, responsive stimulation alone, enhanced nutrition)
Number of subjects: 1302
Study 27342433 — intervention group
Group type: COMPARATOR
Intervention: Routine health and nutrition services (control)
Number of subjects: 1302
Study 24969395 — intervention group
Group type: EXPERIMENTAL
Intervention: BAILAMOS Latin dance program (4-month program, 2 times per week, 1 hour per session)
Number of subjects: 332
Study 24969395 — intervention group
Group type: COMPARATOR
Intervention: Health education control group (1 time per week, 2 hours per session)
Number of subjects: 332
Study 22145610 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-594 150 μg
Number of subjects: 266
Study 22145610 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-594 225 μg
Number of subjects: 266
Study 22145610 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-594 300 μg
Number of subjects: 266
Study 22145610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study 20074276 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon gamma (IFN‐γ)
Number of subjects: 0
Study 17609872 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation alone (50.4 Gy; 5 x 1.8 Gy/week)
Number of subjects: 19
Study 16126756 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified hypo-osmotic swelling (HOS) test
Number of subjects: 79
Study 16126756 — intervention group
Group type: COMPARATOR
Intervention: Morphology selection
Number of subjects: 79
Study 12229137 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine 1.5 mg.kg‐1
Number of subjects: 31
Study 12229137 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 0.75 ml.kg‐1
Number of subjects: 31
Study 12229137 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (L and C)
Number of subjects: 31
Study 10212082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (250 microg/puff, two puffs, 12 hourly for 14 days)
Number of subjects: 53
Study 10212082 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 53
Study 10212082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 10212082 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate and Placebo
Number of subjects: 53
Study 7752567 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper-and-pencil test (P & P)
Number of subjects: 377
Study 7752567 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized adaptive test (CAT)
Number of subjects: 377
Study 7752567 — intervention group
Group type: COMPARATOR
Intervention: Traditional success rate in adaptive testing
Number of subjects: 377
Study 2157354 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% nedocromil sodium eye drops
Number of subjects: 126
Study 2157354 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 126
Study 37542 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 16
Study 37542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 29774510 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored video aimed at increasing enrollment in the Incredible Years® Parent Program
Number of subjects: 215
Study 27687307 — intervention group
Group type: COMPARATOR
Intervention: ACF (Adriamycin 35 mg/m2, cisplatin 70 mg/m2 i.v. on day 1, fluorouracil 700 mg/m2 continuous infusion for 7 days) every 4 weeks
Number of subjects: 162
Study 27687307 — intervention group
Group type: EXPERIMENTAL
Intervention: DCF (docetaxel 70 mg/m2, cisplatin 70 mg/m2 i.v. on day 1, fluorouracil 700 mg/m2 continuous infusion for 5 days) every 3 weeks
Number of subjects: 162
Study 25831100 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach PP‐‐entangled polypropylene floss
Number of subjects: 10
Study 25831100 — intervention group
Group type: EXPERIMENTAL
Intervention: Reach NT‐‐texturized nylon
Number of subjects: 10
Study 23403978 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone calls followed by letters for continued nonadherence
Number of subjects: 5216
Study 23403978 — intervention group
Group type: COMPARATOR
Intervention: No outreach (Control)
Number of subjects: 5216
Study 21549403 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative repair (laparoscopic mesh placement)
Number of subjects: 60
Study 21549403 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (physiotherapy, corticosteroid injections, oral anti-inflammatory analgesics)
Number of subjects: 60
Study 21549403 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative repair
Number of subjects: 60
Study 19140899 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 42
Study 19140899 — intervention group
Group type: COMPARATOR
Intervention: Intensive insulin injection therapy (IIT)
Number of subjects: 42
Study 17728425 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health court program
Number of subjects: 170
Study 17728425 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful completion of the mental health court program
Number of subjects: 170
Study 17728425 — intervention group
Group type: COMPARATOR
Intervention: Standard criminal justice process (Control)
Number of subjects: 170
Study 15166130 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ICSI (mICSI)
Number of subjects: 70
Study 15166130 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 70
Study 12225513 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention (regulations enforcement, face-to-face education, peer influence)
Number of subjects: 22
Study 22462215 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 60
Study 22462215 — intervention group
Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 60
Study 7974375 — intervention group
Group type: EXPERIMENTAL
Intervention: Mononuclear cells from lymphoma patients after 20 h incubation at 37 degrees C
Number of subjects: 12
Study 7974375 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture medium from lymphoma patients' mononuclear cells after 20 h incubation at 37 degrees C
Number of subjects: 12
Study 7974375 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma from lymphoma patients
Number of subjects: 12
Study 2648867 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine 200 mg/day
Number of subjects: 18
Study 2648867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 4580022 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowering diastolic blood pressure levels of between 100 and 120 mm Hg to below 100 mm Hg.
Number of subjects: 58
Study 4580022 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified treatment).
Number of subjects: 58
Study 30872263 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide with androgen-deprivation therapy
Number of subjects: 0
Study 30872263 — intervention group
Group type: COMPARATOR
Intervention: Placebo with androgen-deprivation therapy
Number of subjects: 0
Study 28003557 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxygenation with FIO2 + 0.20 above baseline
Number of subjects: 68
Study 28003557 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxygenation with FIO2 1.0
Number of subjects: 68
Study 28003557 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline values)
Number of subjects: 68
Study 25531343 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 4640
Study 25531343 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine-tenofovir disoproxil fumarate (FTC-TDF)
Number of subjects: 4640
Study 25531343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4640
Study 25531343 — intervention group
Group type: COMPARATOR
Intervention: All groups (TDF, FTC-TDF, and placebo)
Number of subjects: 4640
Study 23239133 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg/day) + Betahistine (48 mg/day)
Number of subjects: 43
Study 23239133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 22403954 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined central and local application of physiotherapeutic techniques (using AVIM‐1 apparatus for vibration and magnetic field application, and AMO‐ATOS‐E device for transcranial magnetotherapy and electrostimulation)
Number of subjects: 98
Study 22403954 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined central and local application of physiotherapeutic techniques
Number of subjects: 98
Study 18613281 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 45
Study 18613281 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list comparison group
Number of subjects: 45
Study 17704973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum extract
Number of subjects: 0
Study 17704973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17704973 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic antidepressive drugs
Number of subjects: 0
Study 17704973 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatoform disorders
Number of subjects: 0
Study 15540297 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 26
Study 15540297 — intervention group
Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 26
Study 11080605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy with nutritional approach
Number of subjects: 60
Study 11080605 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy without nutritional approach
Number of subjects: 60
Study 9846846 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearic acid-rich triacylglycerol
Number of subjects: 15
Study 9846846 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitic acid-rich diet
Number of subjects: 15
Study 9846846 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 15
Study 9846846 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (before study)
Number of subjects: 15
Study 7522088 — intervention group
Group type: EXPERIMENTAL
Intervention: N2 flow
Number of subjects: 100
Study 7522088 — intervention group
Group type: COMPARATOR
Intervention: no N2 flow
Number of subjects: 100
Study 2628134 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (12 micrograms/kg)
Number of subjects: 20
Study 2628134 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg)
Number of subjects: 20
Study 972260 — intervention group
Group type: EXPERIMENTAL
Intervention: P-300
Number of subjects: 26
Study 972260 — intervention group
Group type: COMPARATOR
Intervention: 3% hexachlorophene preparation
Number of subjects: 26
Study 30699420 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT care based on 5E's renal rehabilitation
Number of subjects: 146
Study 30699420 — intervention group
Group type: COMPARATOR
Intervention: Routine care and follow‐up (Control)
Number of subjects: 146
Study 26214543 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of Divorce‐Coping With Divorce (CoD‐CoD)
Number of subjects: 147
Study 26214543 — intervention group
Group type: COMPARATOR
Intervention: Internet self‐study condition, Best of the Net (BTN)
Number of subjects: 147
Study 23743482 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-weekly LSC videos
Number of subjects: 238
Study 23743482 — intervention group
Group type: COMPARATOR
Intervention: 12-weekly HIV prevention messages
Number of subjects: 238
Study 21291434 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental support for fighting
Number of subjects: 5581
Study 21291434 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental support for nonviolence
Number of subjects: 5581
Study 21291434 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental involvement
Number of subjects: 5581
Study 21291434 — intervention group
Group type: EXPERIMENTAL
Intervention: Class-level norms supporting aggression
Number of subjects: 5581
Study 21291434 — intervention group
Group type: EXPERIMENTAL
Intervention: Delinquent peer associations
Number of subjects: 5581
Study 19271169 — intervention group
Group type: EXPERIMENTAL
Intervention: Quyu Jiedu Granules (QJG)
Number of subjects: 20
Study 19271169 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 20
Study 16620350 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 256
Study 16620350 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 256
Study 16620350 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 14711910 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg daily)
Number of subjects: 518
Study 14711910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study 15006431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 7.5 mg
Number of subjects: 9
Study 15006431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 10885352 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg zinc per day as zinc sulphate, 6 days a week for 6 months)
Number of subjects: 200
Study 10885352 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 200
Study 10885352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 9184265 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-10 (IL-10)
Number of subjects: 108
Study 9184265 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 108
Study 9184265 — intervention group
Group type: COMPARATOR
Intervention: C-reactive protein (CRP)
Number of subjects: 108
Study 9184265 — intervention group
Group type: COMPARATOR
Intervention: Alpha-1-acid glycoprotein (AGP)
Number of subjects: 108
Study 9184265 — intervention group
Group type: COMPARATOR
Intervention: Alpha1 antichymotrypsin (ACT)
Number of subjects: 108
Study 9184265 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 and APP correlation
Number of subjects: 108
Study 9184265 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 and APP correlation
Number of subjects: 108
Study 8238640 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (up to 6 mg/day)
Number of subjects: 54
Study 8238640 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine (up to 90 mg/day)
Number of subjects: 54
Study 8238640 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 3804176 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg bd
Number of subjects: 20
Study 3804176 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg bd
Number of subjects: 20
Study 3288675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafast computed tomography
Number of subjects: 62
Study 30307840 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized feedback threatening masculinity
Number of subjects: 867
Study 30326764 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 101
Study 28455782 — intervention group
Group type: EXPERIMENTAL
Intervention: RPC4046
Number of subjects: 0
Study 25748117 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) followed by monthly bacillus Calmette-Guérin (BCG) instillations
Number of subjects: 236
Study 25748117 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin C (MMC) followed by alternating BCG and interferon (IFN)-α2b instillations
Number of subjects: 236
Study 23379741 — intervention group
Group type: EXPERIMENTAL
Intervention: Case Management (CM)
Number of subjects: 278
Study 23379741 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 278
Study 21393298 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone 25-50 mg/day
Number of subjects: 6632
Study 21393298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6632
Study 21393298 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 6632
Study 19957509 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 8610
Study 17123125 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 101
Study 17123125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 15543449 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-lens image-shifting mechanism combined with software designed to track nystagmus.
Number of subjects: 12
Study 11237896 — intervention group
Group type: EXPERIMENTAL
Intervention: Transconjunctival blepharoplasty with immediate CO(2) laser resurfacing
Number of subjects: 44
Study 11237896 — intervention group
Group type: COMPARATOR
Intervention: Transconjunctival blepharoplasty alone
Number of subjects: 44
Study 11237896 — intervention group
Group type: EXPERIMENTAL
Intervention: Transconjunctival blepharoplasty with CO(2) laser resurfacing 2 months later
Number of subjects: 44
Study 9669004 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06 mg.kg‐1 rocuronium
Number of subjects: 120
Study 9669004 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% (control)
Number of subjects: 120
Study 9669004 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium 0.02 mg.kg‐1
Number of subjects: 120
Study 9669004 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 8058290 — intervention group
Group type: EXPERIMENTAL
Intervention: 350-mm2 Baerveldt implant
Number of subjects: 73
Study 8058290 — intervention group
Group type: EXPERIMENTAL
Intervention: 500-mm2 Baerveldt implant
Number of subjects: 73
Study 3052167 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1.5 mg/kg for induction, followed by 10‐min infusion of an induction dose; maintained with continuous infusion of 0.1 mg/kg per min)
Number of subjects: 20
Study 3052167 — intervention group
Group type: COMPARATOR
Intervention: Etomidate (18 mg for induction, followed by 2.4 mg/min for maintenance)
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inhalations during mannitol challenge
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep inhalations during methacholine challenge
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO levels
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsiveness to deep inhalation methacholine
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose‐response slopes from deep inhalation mannitol
Number of subjects: 20
Study 31785175 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose‐response slope from non‐deep inhalation mannitol
Number of subjects: 20
Study 31397597 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen sodium (440 mg)
Number of subjects: 189
Study 28931943 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired Vagus Nerve Stimulation (VNS)
Number of subjects: 30
Study 28931943 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 28931943 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired VNS
Number of subjects: 30
Study 26114906 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (n = 24)
Number of subjects: 48
Study 26114906 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 48
Study 24019420 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (100000 IU, 6 quarterly doses)
Number of subjects: 3046
Study 24019420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3046
Study 24019420 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 3046
Study 22288155 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (600 mg once a day, i.v.)
Number of subjects: 0
Study 22288155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol (300 mg once a day, i.v.)
Number of subjects: 0
Study 22288155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19336459 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural motor cortex stimulation (MCS) 'on'
Number of subjects: 16
Study 19336459 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural motor cortex stimulation (MCS) 'on' during open phase
Number of subjects: 16
Study 19336459 — intervention group
Group type: COMPARATOR
Intervention: Epidural motor cortex stimulation (MCS) 'off'
Number of subjects: 16